Live Meeting: Externally-Led Patient-Focused Drug Development Meeting for People and Families Living with Sensorineural Hearing Loss
Date: Tuesday, May 25, 2021
Time: 10 a.m.-3 p.m. (U.S. Eastern Time)
Patient-Focused Drug Development (PFDD) meetings were first started by the FDA to try and find a better way to hear directly from patients, their caregivers and families. The meetings explore what symptoms matter most to them, the impacts on patients’ daily lives, and patients’ experiences with currently available treatments. This information helps the FDA both during drug development as well as during review of marketing applications for new drugs
It is exciting that HLAA can lead the charge here with the FDA who will attend and listen. Our hope is that patient engagement through a PFDD will go a long way in shaping future hearing loss treatments and creating a deeper understanding of the impact of hearing loss on individuals, their quality of life and associated comorbidities.
Questions? Feel free to email us at webinars@hearingloss.org.